CARRIAGE OF THYROID ANTIBODIES AS A RISK FACTOR IN THE DEVELOPMENT AND PROGRESSION OF ENDOCRINE OPHTHALMOPATHY

Abstract

The influence of the carrier of thyroid autoantibodies (to thyroid-stimulating hormone receptor, to thyroglobulin, to thyroid peroxidase) on the clinical course of endocrine ophthalmopathy (EOP), developed on the background of diffuse toxic goiter (139 patients). We studied the role of carrier of monoantibodies and their combinations. It has been proven a direct link between the presence of the analyzed thyroid autoantibodies and the clinical course of EOP. It is shown that the presence of antibodies to thyroid peroxidase and anti-thyroglobulin antibodies is not a lesser important risk factor for the development of EOP in patients with diffuse toxic goiter than the presence of antibodies to the receptor for thyroid-stimulating hormone, and the multiple carriers is associated with more frequent development of active forms of EOP and higher amplitude of inflammation of the orbit. Thus, serological indices and spectrum of thyroid antibodies revealed the depth of systemic disorders of autoimmunity, associated with an increased risk of the development of local autoimmune inflammation in the orbit and can serve as prognostic risk markers of development of highly active and severe forms of EOP.

Keywords

endocrine ophthalmopathy / risk factor / endocrine ophthalmopathy progression / thyroid antibodies

References

[1] 1.Бровкина А.Ф. Эндокринная офтальмопатия. М.: Гэотар-Мед, 2004. 176 с.

[2] 2.Weetman A.P. Graves’ disease 18352002 // Horm Res. 2003. Vol. 59. P. 114-118.

[3] 3.Лихванцева В.Г., Шеремета М.С., Свириденко Н.Ю., Беловалова И.М., Гарбузов П.И. Клиническое течение эндокринной офтальмопатии при болезни Грейвса в зависимости от эффекта ради- ойодтерапии // Проблемы эндокринологии. 2011. №3 (56). С. 17-20.

[4] 4.Бровкина А.Ф., Павлова Т.Л. Эндокринная офтальмопатия с позиций офтальмолога и эндокринолога // Клиническая офтальмология. 2000. №1. C. 11-14.

[5] 5.Аристархов В. Г., Квасов А. В. К вопросу о причинах и методах лечения пациентов с рецидивом болезни Грейвса // Российский медико-биологический вестник имени академика И.П. Павлова. 2015. Т. 23, №2. C. 106-110.

[6] 6.Khoo T.K., Bahn R.S. Pathogenesis of Graves’ ophthalmopathy: the role of autoantibodies // Thyroid. 2007. Vol. 17, №10. P. 1013-1018.

[7] 7.Wen W., Liu F. Autoantibodies Highly Increased in Patients with Thyroid Dysfunction // Cell. Molec. Immunol. 2007. Vol. 4, №3. P. 233-236.

RIGHTS & PERMISSIONS

Likhvantseva V.G., Afanasyev M.S., Rudenko E.A., Afanasyev С.С., Korosteleva E.V., Budanova S.V., Vygodin V.A.